Hong Kong’s health insurers see profit surge
April 7 2021 by Nick Ferguson
-
Better cat data key to easing region’s growing capacity pressures: Perils’ APAC head
- September 26
As insurance penetration and cat exposure rise in APAC, the availability of better quality data must go hand-in-hand with the growth of alternative capital sources. That leads the cat loss specialist to expand its loss data coverage in Japan & South-East Asia, said Darryl Pidcock.
-
Gen AI prophecy turns reality as insurers count cost benefits
- July 1
Artificial intelligence, blockchain and embedded solutions are delivering tangible cost savings and enabling more competitive premium rates, senior insurance executives told an industry forum.
-
Australia’s 2024 insured nat cat losses top US$1bn: ICA
- June 13
The country saw three weather events this year leading to 144,772 claims with the Christmas and New Year storms accounting for AU$1.3bn, data from the industry body shows.
-
Taiwan non-life sector returns to profitability in 2023
- February 5
Pre-tax profit for the non-life sector totalled US$557m as the drag from Covid-19 related losses eased.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
